MAOIF yields 6.29% · PFE yields 6.13%● Live data
📍 MAOIF pulled ahead of the other in Year 1
Combined, MAOIF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MAOIF + PFE for your $10,000?
Manitou BF SA develops, manufactures, and provides equipment and services for the construction, agriculture, and industry sectors worldwide. It operates in two divisions, Product, and Services & Solutions. The company offers material handling, access, and earthmoving equipment, including rough-terrain fixed, rotating, and heavy-duty telehandlers; rough-terrain, semi-industrial, and industrial forklift trucks; wheeled or tracked skid-steer, articulated, and backhoe loaders; aerial work platforms; and truck-mounted forklifts, as well as warehousing equipment and attachments. It also provides attachments, such as buckets, clamps, fork handling solutions, forks and grapples, jibs, work platforms, skips, sweepers and cleaners, winches, mining accessories, and miscellaneous attachments, as well as backrest, carriage, and interface references. In addition, the company offers value added services comprising technical training, new or refurbished spare parts, after-sales service, machine connectivity, financing solutions, maintenance and warranty extension contracts, rent-to-rent leases, full-service contracts, recovery, repair, and resale of used equipment. The company offers its products through a network of dealers under the Manitou, Gehl, and Mustang by Manitou brands. Manitou BF SA was incorporated in 1954 and is headquartered in Ancenis, France.
Full MAOIF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.